Connect with us

Cannabis News

Country doctors concerned on Ireland’s night walk to legalize cannabis

Published

on

Ireland cannabis

As proposals to liberalize cannabis laws are expected before Ireland’s cabinet in coming weeks, a panel of 20 doctors have raised distress over what they termed as ‘increasingly relaxed attitudes towards marijuana amongst the media, legislators, and commentators.’

The claim is that cannabis has now turned out to be the ubiquitous thing linked to drug-associated admissions to psychiatric hospitals throughout the country, mostly.

Furthermore, it’s the common drug that is involved in the new treatment sessions at a plethora of addiction services in Ireland. The doctors’ concern is that drug’s use during teenage increases risks of mental illness as well as impairments to thinking and memory.

Personal Possession of Cannabis

The proposals aimed at liberalizing the country’s drug laws are due to be brought to the Cabinet of the country in the coming days by the Minister of State for Drug Strategy Catherine Byrne.

The plans are that individuals caught with a little amount of the drugs will either be referred to a counseling or addiction service rather than being prosecuted.

The proposals came after a working group set in 2017 spent more than a year trying to examine alternative approaches to personal possession of illegal drugs. However, the group chaired by retired judge Garrett Sheehan didn’t produce an agreed report over the same issue.

Decriminalization

According to the doctors, decriminalization and legalization is different but agreed that both medical cannabis and decriminalization campaigns have all proven to be effective strategies to full legalization as well as commercialization in other dominions.

However, they claim that the general public is in the dark and are not being told about the harmful side of cannabis. Although, they say that the detrimental effects are now magnified with the prevalence of a potent form of cannabis than it was in early days.

For medical cannabis, the Department of Health is set to announce an access program within weeks. Therefore, it will put to rest the requirement for a doctor to secure a license before prescribing cannabis to patients with certain conditions.

For the latest marijuana industry news updates and the hottest MJ stocks, sign up below!

Photo by Steven Hylands from Pexels

Cannabis News

Why the ACMPR Is So Popular with Medical Marijuana Patients in Canada

Published

on

ACMPR

Depending on your home country, accessing medical marijuana may just be easier than ever for you. This is the case for North Americans, Canadians in particular. Since the early 2000s, Canada has been successfully implementing a medical marijuana program for patients called the ACMPR. 

Although this program (also referred to as the MMPR and MMAR in the past) has been around in some form or another for decades, it is continuing to grow in popularity. But why? It’s not just because Canadians want an excuse to grow cannabis plants from home… 

What Is the ACMPR?

Before discussing the growing popularity of the ACMPR program, it’s important to have a solid understanding of what it actually is. ACMPR stands for Access to Cannabis for Medical Purposes Regulations. For those who are eligible and have a valid medical condition that requires the use of cannabis for treatment, the ACMPR allows for easy access to cannabis. 

Not only does it allow medical patients to easily access medical-grade marijuana from licensed producers throughout the country, but it allows patients to cultivate their own plants from home. Unlike the recreational cannabis laws which allow citizens to grow no more than 4 plants from home, the ACMPR determines plant counts based on medical needs. 

Canadians who use the ACMPR license to grow from home have a predetermined plant count based on the number of grams prescribed per day. For example, if you receive a prescription…

Continue Reading

Cannabis News

Why Buy From Marijuana Seed Banks?

Published

on

marijuana seed banks

If you’re interested in growing marijuana and live in a state that allows its cultivation, then you might want to consider buying seeds from seed banks. Some of the best cannabis get cultivated outside the country, which means that, sometimes, you have to find a seed bank that ships to the US. 

There are a lot of options when it comes to sources for marijuana seeds online. However, not all of them can ship to the US due to strict regulations in the country. Thus, it’s best to find a legit seed bank that can process orders from United States customers.  

Avoid transacting with other sources aside from seed banks. If you do so, you run the risk of receiving low-quality products, wasting your money in the end. Look for a company with positive feedback and has a proven history of dealing with US customers. Some of the most popular ones include Seedsman and I Love Growing Marijuana (IGLM). You can check out GreenBudGuru’s Seedsman review and their review of other companies to find the best fit for your needs.

If you’re looking to get your seeds online, below are some reasons you should buy marijuana seeds from a trusted and reliable marijuana seed banks.

You Don’t Have Any Other Option

As mentioned above, some states in the US still don’t allow local buying and selling of marijuana, even if medical marijuana consumption has already gained momentum. If…

Continue Reading

Cannabis News

22nd Century Group Inc (NYSE:XXII): 3 Reasons You May Want To Buy The Stock This Month

Published

on

NYSE:XXII

The tobacco industry is huge and growing. The cannabis industry is already booming yet it is only in the early stages of development and the future looks incredibly bright as more countries legalize pot. 22nd Century Group Inc (NYSE:XXII) is the stock that offers investors the chance to own the best of both tobacco and cannabis worlds.

The stock currently trades at $1.00/share. But that is not where it belongs as that is its lowest watermark. As recently as September, NYSE:XXII was trading above $2.40/share.

About NYSE:XXII

For investors who may have just come across 22nd Century Group for the very first time, here is a brief profile of the company. 22nd Century Group is a plant biotechnology company and a leader in tobacco harm reduction. It has also set its sight on the legal hemp and cannabis industries. In the tobacco space, NYSE:XXII has developed a low-nicotine tobacco plant variety. In the hemp/cannabis space, the company is working to develop hemp and cannabis plants with specific desirable qualities.

If you are looking to have a footing in both tobacco and cannabis industries, here are three reasons you may want to buy NYSE:XXII.

  • 22nd Century Group on track to take control of CBD products maker Panacea Life Sciences

On December 3, 22nd Century…

Continue Reading

MJ Stocks